Skip to main content
Log in

Effects of mecamylamine on human cigarette smoking and subjective ratings

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Multiple measures of cigarette smoking, subjective effect and physiological effect were collected during 90-min test sessions in normal volunteers. Before sessions subjects received oral doses of mecamylamine (2.5, 5.0, 10, 20 mg) or placebo. Each dose and placebo was given three times in a randomized block sequence. Mecamylamine increased several measures of cigarette smoking, including number of cigarettes, number of puffs per cigarette, and expired air carbon monoxide level. Mecamylamine also produced modest, dose-related decreases in standing blood pressure and increases in standing heart rate. The subjective effects produced by mecamylamine were not characteristic of those of psychoactive drugs. Mecamylamine appears to have increased cigarette smoking by decreasing the effective dose level of nicotine available from cigarette smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Chait LD, Griffiths RR (1982) Differential control of puff duration and interpuff interval in cigarette smokers. Pharmacol Biochem Behav 17:155–158

    Google Scholar 

  • Chait LD, Griffiths RR (1983) Effects of caffeine on cigarette smoking and subjective response. Clin Pharmacol Ther 34:612–622

    Google Scholar 

  • Chait LD, Griffiths RR (1984) Effects of methadone administration on human cigarette smoking and subjective response. J Pharmacol Exp Ther 229:636–640

    Google Scholar 

  • Goldberg SR, Spealman RD, Risner MD, Henningfield JE (1983) control of behavior by intravenous nicotine injection in laboratory animals. Pharmacol Biochem Behav 19:1011–1020

    Google Scholar 

  • Goldberg SR, Woods JH, Schuster CR (1969) Morphine: Conditioned increases in self-administration in rhesus monkeys. Science 166:1307–1307

    Google Scholar 

  • Griffiths RR, Bigelow G, Henningfield JE (1980) Similarities in animal and human drug taking behavior. In: Mello NK (ed) Advances in substance abuse: Behavioral and biological research. Greenwich, CT: JAI Press, pp 1–90

    Google Scholar 

  • Griffiths RR, Henningfield JE (1982a) Experimental analysis of human cigarette smoking behavior. Fed Proc 41:234–240

    Google Scholar 

  • Griffiths RR, Henningfield JE (1982b) Pharmacological aspects of cigarette smoking. TIPS 3:260–263

    Google Scholar 

  • Griffiths RR, Wurster J, Brady JV (1981) Choice between food and heroin: Effects of morphine, naloxone and secobarbital. J Exp Anal Behav 35:335–351

    Google Scholar 

  • Gritz ER (1980) Smoking behavior and tobacco abuse. In: Mello NK (ed) Advances in substance abuse: Behavioral and biological research. Greenwich, CT: JAI Press, pp 91–158

    Google Scholar 

  • Haertzen CA, Hickey JE (1985) Measurement of euphoria and other drug effects. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Brunswick, Maine: Haer Institute (in press)

    Google Scholar 

  • Henningfield JE (1984) Behavioral pharmacology of cigarette smoking. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology Vol IV, New York: Academic Press

    Google Scholar 

  • Henningfield JE, Chait LD, Griffiths RR (1983a) Cigarette smoking and subjective responses in alcoholics: Effects of pentobarbital. Clin Pharmacol Ther 33:806–812

    Google Scholar 

  • Henningfield JE, Chait LD, Griffiths RR (1984) Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism. Psychopharmacology 82:1–5

    Google Scholar 

  • Henningfield JE, Goldberg SR (1983) Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 19:989–992

    Google Scholar 

  • Henningfield JE, Griffiths RR (1979) A preparation for the experimental analysis of human cigarette smoking behavior. Behav Res Methods Instrum 11:538–544

    Google Scholar 

  • Henningfield JE, Miyasato K, Jasinski DR (1983b) Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav 19:887–890

    Google Scholar 

  • Henningfield JE, Miyasato K, Johnson RE, Jasinski DR (1983c) Rapid physiological effects of nicotine in humans and selective blockade of behavioral effects by mecamylamine. National Institute on Drug Abuse Research Monograph, Volume 43, Problems of Drug Dependence, 1982 Government Printing Office, pp 259–265

  • Jarvik ME, Glick SD, Nakamura RK (1970) Inhibition of cigarette smoking by orally administered nicotine. Clin Pharmacol Ther 11:574–576

    Google Scholar 

  • Jarvis MJ, Russell MAH, Saloojee Y (1980) Expired air carbon monoxide: A sample breath test of tobacco smoke intact. Br Med J 281:484–485

    Google Scholar 

  • Jarvis M (1983) Treatment of cigarette dependence. Br J Addict 78:125–130

    Google Scholar 

  • Keppel G (1973) Design and analysis: A researcher handbook. Englewood Cliffs. NJ: Prentice Hall

    Google Scholar 

  • Kozlowski LT, Jarvik ME, Gritz ER (1975) Nicotine regulation and cigarette smoking. Clin Pharmacol Ther 17:93–97

    Google Scholar 

  • Lucchesi BR, Schuster CR, Emley AB (1967) Role of nicotine as a determination of cigarette smoking frequency in man with observation of certain cardiovascular effects associated with the tobacco alkaloid. Clin Pharmacol Ther 22:789–796

    Google Scholar 

  • McMorrow MJ, Foxx RM (1983) Nicotine's role in smoking: An analysis of nicotine regulation. Psychol Bull 93:302–327

    Google Scholar 

  • Moss RA, Prue DM (1982) Research on nicotine regulation. Behav Ther 13:31–46

    Google Scholar 

  • Nemeth-Coslett R, Griffiths RR (1984a) Determinants of puff duration in cigarette smokers: I. Pharmacol Biochem Behav 20:965–971

    Google Scholar 

  • Nemeth-Coslett R, Griffiths RR (1984b) Determinants of puff duration in cigarette smokers: II. Pharmacol Biochem Behav 21:903–912

    Google Scholar 

  • Rose JE, Jarvik ME, Anada S (1984) Nicotine preference increases after cigarette deprivation. Pharmacol Biochem Behavior 20:55–58

    Google Scholar 

  • Stepney R (1980) Consumption of cigarettes of reduced tar and nicotine delivery. Br J Addict 75:81–88

    Google Scholar 

  • Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 28:217–259

    Google Scholar 

  • Tennant FS, Tarver AL, Rawson RA (1984) Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. In: Harris LS (ed) Problems of drug dependence, National Institute on Drug Abuse, Research Monograph, Volume 49, (ADM) 84–1316, Washington, D.C., Government Printing Office

    Google Scholar 

  • Woods JH, Downs DA, Carney J (1975) Behavioral functions of narcotic antagonists: Response-drug contingencies. Fed Proc 34:1777–1784

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nemeth-Coslett, R., Henningfield, J.E., O'Keeffe, M.K. et al. Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88, 420–425 (1986). https://doi.org/10.1007/BF00178502

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00178502

Key words

Navigation